|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
Ƥ��ģ���� |
|
��Ƥ֧���� |
|
������ |
| ��������������� | |
|
½�� |
|
������ |
| PubMed | |
|
Article by |
|
Article by |
����Ƥ��ģ������о���չ
½��, ������
�Ϻ��ڶ�ҽ�ƴ�ѧ�������ҽԺƤ����, 200025
���⽨��Ƥ��ģ����ļ�����Ҫ��ָ��ȥ��Ƥ����Ƥ��֯��(��)������άϸ���Ľ�ԭ�����Ͻ��б�Ƥϸ������.��ЩƤ��ģ�����������������Ƥ�����Ƶij��ṹ����̬ѧ����.������֯����ѧ�����ķ�չ,���ø÷�����������Ʒ����Ƥ��ģ������Apligraf��Epi Derm��Melano Derm��,���ѹ㷺���ڶ�Ƥ������ĸ���,����,���˵ȵ�����,��ҩ���ҩ������ͻ�ѧ�ϳ���Ķ��������.�ֽ��Խ������й�����Ƥ��ģ���ｨ���ķ�������Ӧ�÷���Ľ�չ��������.
[2] Topoi BM,Haimes HB,Dubertret L,et al.Transfer of melanosomes in a skin equivalent model in vitro.J Invest Dermatol,1986,87(5):642-647.
[3] Michel M,L Heureux N,Pouliot R,et al.Characterization of a new tissue-engineered human skin equivalent with hair.In Vitro Cell Dev Biol Anim,1999,35(6);318-326.
[4] Black AF,Hudon V,Damour O,et al.A novel approach for studying angiogenesis:a human skin equivalent with a capillary-like network.Cell Biol Toxicol,1999,15(2);81-90.
[5] Falabella AF,Schachner LA,Valencia IC,et al.The use of tissueengineered skin(Apligraf)to treat a newborn with epidermolysis bullosa.Arch Dermatol,1999,135(10):1219-1222.
[6] de Imus G,Golomb C,Wilkel C,et al.Accelerated healing of pyoderma gangrenosum treated with bioengineered skin and concomitant immunosuppression.J Am Acad Dermatol,2001,44(1);61-66.
[7] Streit M,Bohlen LM,Braathen LR.Ulcerative sarcoidosis successfully treated with apligraf.Dermatology,2001,202(4);367-370.
[8] Muhart M,McFalls S,Kirsner RS,et al.Behavior of tissue-engineered skin:a comparison of a living skin equivalent,autograft,and occlusive dressing in human donor sites.Arch Dermatol,1999,135(8):913-918.
[9] Brem H,Balledux J,Bloom T,et al.Healing of diabetic foot ulcers and pressure ulcers with human skin equivalent:a new paradigm in wound healing.A.rch Surg,2000,135(6),:627-634.
[10] Perkins MA,Osborne R,Rana FR,et al.Comparison of in vitro and in vivo human skin responses to consumer products and ingredients with a range of irritancy potential.Toxieol Sci,1999,48(2);218-229.
[11] Medina J,de Brugerolle de Fraissinette,Chibout SD,et al.Use of human skin equivalent Apligraf for in vitro assessment of cumulative skin irritation potential of topical products.Toxicol Appl Pharmacol,2000,164(1);38-45.
[12] Asbill C,Kim N,El-Kattan A,et al.Evaluation of a human bio-engineered skin equivalent for drug permeation studies.Pharm Res,2000,17(9);1092-1097.
[13] Schmook FP,Meingassner JG,Billich A.Comparison of human skin or epidermis models with human and animal skin in in-vitro percutaneous absorption.Int J Pharm,2001,215(1-2);51-56.
[14] Zhao JF,Zhang YJ,Kubilus J,et al.Reconstituted 3-dimensional human skin as a novel in vitro model for studies of carcinogenesis.Biochem Biophys Res Commun,1999,254(1);49-53.
[15] Obi-Tabot ET,Tian XQ,Chen TC,et al.A human skin equivalent model that mimics the photoproduction of vitamin Ds in human skin.In Vitro Cell Der Biol Anim,2000,36(3);201-204.